LEMAITRE VASCULAR, INC. Capital Expenditures
LEMAITRE VASCULAR, INC. (LMAT) reported Capital Expenditures of $2.84 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2017-03-09
- LEMAITRE VASCULAR, INC. payments to acquire property, plant, and equipment for the quarter ending 2016-03-31 was $720.00K, a 122.91% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire property, plant, and equipment for the quarter ending 2015-12-31 was $715.00K, a 78.75% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire property, plant, and equipment for the quarter ending 2015-09-30 was $765.00K, a 240.00% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire property, plant, and equipment for the quarter ending 2015-06-30 was $470.00K, a 305.17% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire property, plant, and equipment for fiscal 2016 was $2.84M, a 24.99% increase from fiscal 2015.
- LEMAITRE VASCULAR, INC. payments to acquire property, plant, and equipment for fiscal 2015 was $2.27M, a 93.61% increase from fiscal 2014.
- LEMAITRE VASCULAR, INC. payments to acquire property, plant, and equipment for fiscal 2014 was $1.17M, a 57.04% decline from fiscal 2013.
- LEMAITRE VASCULAR, INC. payments to acquire property, plant, and equipment for fiscal 2013 was $2.73M, a 126.05% increase from fiscal 2012.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2016-12-31 | $2.84M 10-K · filed 2017-03-09 | |||
| 2016-03-31 | $720.00K 10-Q · filed 2016-05-06 | $1.44M derived: sum of 2 quarters · filed 2017-03-09 | $2.20M derived: sum of 3 quarters · filed 2017-03-09 | $2.67M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-12-31 | $715.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $1.48M derived: sum of 2 quarters · filed 2017-03-09 | $1.95M derived: sum of 3 quarters · filed 2017-03-09 | $2.27M 10-K · filed 2017-03-09 |
| 2015-09-30 | $765.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.24M derived: sum of 2 quarters · filed 2015-11-06 | $1.56M 10-Q · filed 2015-11-06 | $1.96M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $470.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $793.00K 10-Q · filed 2015-08-06 | $1.19M derived: sum of 3 quarters · filed 2017-03-09 | $1.42M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $323.00K 10-Q · filed 2016-05-06 | $723.00K derived: sum of 2 quarters · filed 2017-03-09 | $948.00K derived: sum of 3 quarters · filed 2017-03-09 | $1.06M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $625.00K derived: sum of 2 quarters · filed 2017-03-09 | $741.00K derived: sum of 3 quarters · filed 2017-03-09 | $1.17M 10-K · filed 2017-03-09 |
| 2014-09-30 | $225.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $341.00K derived: sum of 2 quarters · filed 2015-11-06 | $774.00K 10-Q · filed 2015-11-06 | $1.07M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $549.00K 10-Q · filed 2015-08-06 | $844.00K derived: sum of 3 quarters · filed 2016-03-10 | $1.22M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $433.00K 10-Q · filed 2015-05-07 | $728.00K derived: sum of 2 quarters · filed 2016-03-10 | $1.11M derived: sum of 3 quarters · filed 2016-03-10 | $2.49M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $675.00K derived: sum of 2 quarters · filed 2016-03-10 | $2.06M derived: sum of 3 quarters · filed 2016-03-10 | $2.73M 10-K · filed 2016-03-10 |
| 2013-09-30 | $380.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.76M derived: sum of 2 quarters · filed 2014-11-06 | $2.44M 10-Q · filed 2014-11-06 | $2.86M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.06M 10-Q · filed 2014-08-07 | $2.48M derived: sum of 3 quarters · filed 2015-03-18 | $2.68M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-03-31 | $676.00K 10-Q · filed 2014-05-08 | $1.10M derived: sum of 2 quarters · filed 2015-03-18 | $1.30M derived: sum of 3 quarters · filed 2015-03-18 | $1.61M derived: sum of 4 quarters · filed 2015-03-18 |
| 2012-12-31 | $421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $625.00K derived: sum of 2 quarters · filed 2015-03-18 | $938.00K derived: sum of 3 quarters · filed 2015-03-18 | $1.21M 10-K · filed 2015-03-18 |
| 2012-09-30 | $204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $517.00K derived: sum of 2 quarters · filed 2013-11-07 | $788.00K 10-Q · filed 2013-11-07 | $1.41M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $313.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $584.00K 10-Q · filed 2013-08-09 | $1.20M derived: sum of 3 quarters · filed 2014-03-21 | $1.85M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $271.00K 10-Q · filed 2013-05-08 | $888.00K derived: sum of 2 quarters · filed 2014-03-21 | $1.54M derived: sum of 3 quarters · filed 2014-03-21 | $1.78M derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | $617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $1.27M derived: sum of 2 quarters · filed 2014-03-21 | $1.51M derived: sum of 3 quarters · filed 2014-03-21 | $2.02M 10-K · filed 2014-03-21 |
| 2011-09-30 | $650.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $889.00K derived: sum of 2 quarters · filed 2012-11-09 | $1.40M 10-Q · filed 2012-11-09 | $2.72M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-06-30 | $239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $754.00K 10-Q · filed 2012-08-10 | $2.07M derived: sum of 3 quarters · filed 2013-03-27 | $2.62M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-03-31 | $515.00K 10-Q · filed 2012-05-03 | $1.83M derived: sum of 2 quarters · filed 2013-03-27 | $2.38M derived: sum of 3 quarters · filed 2013-03-27 | |
| 2010-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $1.86M derived: sum of 2 quarters · filed 2013-03-27 | $2.47M 10-K · filed 2013-03-27 | |
| 2010-09-30 | $542.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $1.15M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $609.00K 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $577.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |